典必殊辅助治疗病毒性角膜炎的疗效观察

典必殊辅助治疗病毒性角膜炎的疗效观察
蒋敏;蒋捷;张燕
【期刊名称】《中国医药导报》
【年(卷),期】2011(8)1
【摘要】Objective: To observe clinical efficacy of Tobradex adjuvant therapy for herpes simplex keraticis. Methods: 54 patients with herpes simplex virus keratitis were randomly divided into treatment group and control group, control group was given 0.1％ Acyclovir eye drops and bFGF eye drops dripped eye alternately, once two hours; treatment group was given 0.1％ Acyclovir eye drops and Tobradex eye drops dripped eye alternately, once two hours. Results: The deep type, effective rate of treatment group (87.5％) was obviously better than that of control group (66.7％), the difference was statistically significant between two groups (P ＜0.05). Shallow type, effective rate of two groups were 100.0％. Conclusion: The adjuvant therapy of Tobradex for HSK, a significant synergistic effect can improve the cure rate, shorten the course, reduce relapse, especially for deep-type effect more pronounced.%目的:观察典必殊辅助治疗病毒性角膜炎的临床疗效.方法:将54例病毒性角膜炎患者随机分为治疗组和对照组,对照组给予0.1%无环鸟苷滴眼液与贝复舒滴眼液交替滴眼,1次/2 h;治疗组给予0.1%无环鸟苷滴眼液与典必殊滴眼液交替滴眼,1次/2 h.结果:对深层型,治疗组有效率(87.5%)明显优于对照组(66.7%),两组比较.差异有统计学意义(P＜
0.05).浅层型,两组有效率均为100.0%.结论:典必殊辅助治疗HSK,具有明显的协同作用,能提高治愈率,缩短病程,降低复发,特别对深层型疗效更显著.
【总页数】2页(P80-81)
【作者】蒋敏;蒋捷;张燕
【作者单位】广东省深圳市福田区第二人民医院眼科,广东,深圳,518049;广东省深圳市福田区第二人民医院眼科,广东,深圳,518049;广东省深圳市福田区第二人民医院眼科,广东,深圳,518049
【正文语种】中文
【中图分类】R772.21
【相关文献】
1.典必殊联合阿昔洛韦滴眼液治疗病毒性角膜炎患者的疗效观察 [J], 李淑琴
2.糖皮质激素辅助治疗老年带状疱疹病毒性角膜炎的疗效及对血清相关指标的影响[J], 冯小梅;李群英
3.静脉滴注炎琥宁辅助治疗带状疱疹病毒性角膜炎的可行性研究 [J], 邓茂;廖永梅;刘宏锦
4.典必殊联合阿昔洛韦治疗单疱病毒性角膜炎的疗效观察 [J], 薛秋萍
5.病毒性角膜炎方联合更昔洛韦眼用凝胶治疗病毒性角膜炎的疗效观察 [J], HAO Si-yan;BI Hong-sheng
因版权原因，仅展示原文概要，查看原文内容请购买。